share_log

Legend Biotech | 6-K: Legend Biotech Announced Results for the First Time from the Phase 2 CARTITUDE-2 Cohort D Study in Multiple Myeloma Patients

Legend Biotech | 6-K: Legend Biotech Announced Results for the First Time from the Phase 2 CARTITUDE-2 Cohort D Study in Multiple Myeloma Patients

传奇生物 | 6-K:传奇生物公布西达基奥仑赛针对多发性骨髓瘤患者2期研究积极结果
美股SEC公告 ·  06/03 16:09
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息